Meta-Analysis of Dropout Rates in SSRIs Versus Placebo in Randomized Clinical Trials of PTSD
- 1 February 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 198 (2) , 116-124
- https://doi.org/10.1097/nmd.0b013e3181cc41b6
Abstract
Meta-analysis was conducted to examine dropout predictors and differences between SSRIs and placebo in randomized clinical trials (RCTs) of PTSD. Studies systematically located were SSRI versus placebo double blind RCTs of PTSD DSM diagnosis published between 1991 and 2008. Fourteen RCTs (n = 2815) met the inclusion criteria with an average duration of 10.8 weeks. Dropout rates were: 331 of 1111 (29.8%) among placebo arm and 513 of 1704 (30.3%) among SSRI participants. Random effects modeling showed that the dropout rates of SSRIs and placebo did not differ (OR = 1.05, 95% CI = 0.82-1.34), although favored SSRIs among civilian traumas (OR = 2.52, 95% CI = 1.11-5.7). Mixed effects modeling showed dropout was predicted by mixed trauma in the placebo arms, and duration and mean dose across treatments. With the exception of civilian trauma, SSRIs dropout rates were slightly lower than those of placebo. Formulae are available to guide the prediction of dropout.Keywords
This publication has 63 references indexed in Scilit:
- Nonresponse and Dropout Rates in Outcome Studies on PTSD: Review and Methodological ConsiderationsPsychiatry: Interpersonal & Biological Processes, 2008
- Dropout Rates in Randomized Clinical Trials of Antipsychotics: A Meta-analysis Comparing First- and Second-Generation Drugs and an Examination of the Role of Trial Design FeaturesSchizophrenia Bulletin, 2008
- The Association of Dropout and Outcome in Trials of Antipsychotic Medication and Its Implications for Dealing With Missing DataSchizophrenia Bulletin, 2007
- Failed Efficacy of Fluoxetine in the Treatment of Posttraumatic Stress DisorderJournal of Clinical Psychopharmacology, 2007
- PTSD in Urban Primary Care: High Prevalence and Low Physician RecognitionJournal of General Internal Medicine, 2007
- Paroxetine Response and Tolerability Among Ethnic Minority Patients With Mood or Anxiety DisordersThe Journal of Clinical Psychiatry, 2005
- Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: Preliminary observations on a possible predictor of clinical treatment responseLife Sciences, 1994
- A Controlled Trial of Lithium Augmentation in Fluvoxamine-Refractory Obsessive-Compulsive DisorderJournal of Clinical Psychopharmacology, 1991
- Somatic Complaints, Stress Reaction, and Posttraumatic Stress Disorder: A Three-Year Follow-up StudyBehavioral Medicine, 1988
- Post-Traumatic Stress Disorder in the General PopulationNew England Journal of Medicine, 1987